A germline gene mutation in BRCA1 or BRCA2 results in a significantly elevated lifetime risk of developing breast and ovarian cancer estimated at up to 7 and 25 times, respectively, compared to average risk population. The gene discussed is BRCA1; the disease is ovarian cancer.